HEADER TRANSCRIPTION 19-JAN-09 2RQ4 TITLE REFINEMENT OF RNA BINDING DOMAIN 3 IN CUG TRIPLET REPEAT RNA-BINDING TITLE 2 PROTEIN 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CUG-BP- AND ETR-3-LIKE FACTOR 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RNA RECOGNITION MOTIF; COMPND 5 SYNONYM: CELF-1, BRUNO-LIKE PROTEIN 2, RNA-BINDING PROTEIN BRUNOL-2, COMPND 6 CUG TRIPLET REPEAT RNA-BINDING PROTEIN 1, CUG-BP1, DEADENYLATION COMPND 7 FACTOR CUG-BP, 50 KDA NUCLEAR POLYADENYLATED RNA-BINDING PROTEIN, COMPND 8 EMBRYO DEADENYLATION ELEMENT-BINDING PROTEIN HOMOLOG, EDEN-BP COMPND 9 HOMOLOG; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CUGBP1; SOURCE 6 EXPRESSION_SYSTEM: E. COLI-CELL-FREE SYNTHESIS; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: P040329-21 KEYWDS RRM DOMAIN, RBD, ACTIVATOR, ALTERNATIVE SPLICING, CYTOPLASM, MRNA KEYWDS 2 PROCESSING, NUCLEUS, PHOSPHOPROTEIN, RNA-BINDING, TRANSCRIPTION, KEYWDS 3 STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL KEYWDS 4 AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS KEYWDS 5 INITIATIVE, RSGI EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR K.TSUDA,K.KUWASAKO,M.TAKAHASHI,T.SOMEYA,M.INOUE,T.TERADA,N.KOBAYASHI, AUTHOR 2 M.SHIROUZU,T.KIGAWA,P.GUNTERT,Y.MUTO,S.YOKOYAMA,RIKEN STRUCTURAL AUTHOR 3 GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 2 16-MAR-22 2RQ4 1 REMARK SEQADV REVDAT 1 04-AUG-09 2RQ4 0 JRNL AUTH K.TSUDA,K.KUWASAKO,M.TAKAHASHI,T.SOMEYA,M.INOUE,T.TERADA, JRNL AUTH 2 N.KOBAYASHI,M.SHIROUZU,T.KIGAWA,A.TANAKA,S.SUGANO,P.GUNTERT, JRNL AUTH 3 Y.MUTO,S.YOKOYAMA JRNL TITL STRUCTURAL BASIS FOR THE SEQUENCE-SPECIFIC RNA-RECOGNITION JRNL TITL 2 MECHANISM OF HUMAN CUG-BP1 RRM3 JRNL REF NUCLEIC ACIDS RES. 2009 JRNL REFN ESSN 1362-4962 JRNL PMID 19553194 JRNL DOI 10.1093/NAR/GKP546 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : AMBER 9.0 REMARK 3 AUTHORS : CASE, DARDEN, CHEATHAM, III, SIMMERLING, WANG, REMARK 3 DUKE, LUO, ... AND KOLLM REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2RQ4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 27-JAN-09. REMARK 100 THE DEPOSITION ID IS D_1000150150. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 120 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.37MM [U-100% 13C; U-100% 15N] REMARK 210 PROTEIN, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D 1H-15N NOESY; 3D 1H-13C NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XWINNMR 3.5, NMRPIPE 20030801, REMARK 210 NMRVIEW 5.0.4, KUJIRA 0.9297, REMARK 210 CYANA 2.0.17 REMARK 210 METHOD USED : DGSA-DISTANCE GEOMETRY SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 40 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 377 -0.47 71.66 REMARK 500 1 SER A 387 6.49 -64.27 REMARK 500 1 ASP A 482 -33.13 -151.95 REMARK 500 2 GLN A 386 -53.69 -141.39 REMARK 500 2 LYS A 484 -21.23 -140.81 REMARK 500 3 LYS A 484 133.29 76.36 REMARK 500 4 SER A 380 -46.25 -167.96 REMARK 500 4 ALA A 390 -54.13 67.87 REMARK 500 5 LEU A 383 14.75 -151.66 REMARK 500 5 MET A 469 16.16 -141.05 REMARK 500 6 SER A 381 -167.73 68.23 REMARK 500 6 GLN A 386 11.22 -145.69 REMARK 500 6 ALA A 390 -59.64 -156.51 REMARK 500 6 SER A 488 -47.09 -166.66 REMARK 500 7 SER A 380 6.29 -157.54 REMARK 500 7 LYS A 484 -111.13 52.77 REMARK 500 8 SER A 377 -54.16 -165.74 REMARK 500 8 SER A 387 48.87 -79.70 REMARK 500 8 ALA A 390 -38.82 -170.27 REMARK 500 8 MET A 469 24.45 -140.78 REMARK 500 8 ARG A 478 33.18 -162.30 REMARK 500 8 SER A 483 33.77 -140.94 REMARK 500 9 SER A 387 40.45 -159.81 REMARK 500 9 SER A 479 -46.75 -148.69 REMARK 500 9 LYS A 480 -14.35 -149.29 REMARK 500 9 SER A 485 -170.23 69.40 REMARK 500 10 ASN A 439 11.70 59.35 REMARK 500 10 LYS A 480 13.95 -143.92 REMARK 500 10 ASP A 482 10.15 -144.66 REMARK 500 11 SER A 387 0.59 -66.44 REMARK 500 11 ASN A 481 40.37 -157.88 REMARK 500 11 SER A 483 17.13 -154.47 REMARK 500 12 SER A 479 78.42 68.03 REMARK 500 13 SER A 377 -34.23 70.13 REMARK 500 13 GLN A 386 25.07 -155.36 REMARK 500 13 ALA A 390 -51.50 65.83 REMARK 500 13 ASP A 482 -42.91 68.73 REMARK 500 14 ALA A 390 -47.05 -166.19 REMARK 500 14 SER A 483 -0.39 -153.07 REMARK 500 15 ALA A 390 -40.36 68.98 REMARK 500 15 SER A 479 7.51 -155.90 REMARK 500 15 ASP A 482 23.85 -149.26 REMARK 500 16 LEU A 383 -179.17 66.15 REMARK 500 16 ARG A 478 167.46 65.02 REMARK 500 16 ASP A 482 16.65 -144.82 REMARK 500 16 LYS A 484 36.17 -78.61 REMARK 500 17 THR A 384 -90.39 52.62 REMARK 500 17 GLN A 385 14.93 -141.85 REMARK 500 18 SER A 381 -0.66 65.11 REMARK 500 19 SER A 387 26.59 -73.59 REMARK 500 REMARK 500 THIS ENTRY HAS 54 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2CPZ RELATED DB: PDB DBREF 2RQ4 A 383 484 UNP Q92879 CELF1_HUMAN 383 484 SEQADV 2RQ4 GLY A 376 UNP Q92879 EXPRESSION TAG SEQADV 2RQ4 SER A 377 UNP Q92879 EXPRESSION TAG SEQADV 2RQ4 SER A 378 UNP Q92879 EXPRESSION TAG SEQADV 2RQ4 GLY A 379 UNP Q92879 EXPRESSION TAG SEQADV 2RQ4 SER A 380 UNP Q92879 EXPRESSION TAG SEQADV 2RQ4 SER A 381 UNP Q92879 EXPRESSION TAG SEQADV 2RQ4 GLY A 382 UNP Q92879 EXPRESSION TAG SEQADV 2RQ4 SER A 485 UNP Q92879 EXPRESSION TAG SEQADV 2RQ4 GLY A 486 UNP Q92879 EXPRESSION TAG SEQADV 2RQ4 PRO A 487 UNP Q92879 EXPRESSION TAG SEQADV 2RQ4 SER A 488 UNP Q92879 EXPRESSION TAG SEQADV 2RQ4 SER A 489 UNP Q92879 EXPRESSION TAG SEQADV 2RQ4 GLY A 490 UNP Q92879 EXPRESSION TAG SEQRES 1 A 115 GLY SER SER GLY SER SER GLY LEU THR GLN GLN SER ILE SEQRES 2 A 115 GLY ALA ALA GLY SER GLN LYS GLU GLY PRO GLU GLY ALA SEQRES 3 A 115 ASN LEU PHE ILE TYR HIS LEU PRO GLN GLU PHE GLY ASP SEQRES 4 A 115 GLN ASP LEU LEU GLN MET PHE MET PRO PHE GLY ASN VAL SEQRES 5 A 115 VAL SER ALA LYS VAL PHE ILE ASP LYS GLN THR ASN LEU SEQRES 6 A 115 SER LYS CYS PHE GLY PHE VAL SER TYR ASP ASN PRO VAL SEQRES 7 A 115 SER ALA GLN ALA ALA ILE GLN SER MET ASN GLY PHE GLN SEQRES 8 A 115 ILE GLY MET LYS ARG LEU LYS VAL GLN LEU LYS ARG SER SEQRES 9 A 115 LYS ASN ASP SER LYS SER GLY PRO SER SER GLY HELIX 1 1 THR A 384 GLY A 389 5 6 HELIX 2 2 GLY A 413 MET A 422 1 10 HELIX 3 3 PRO A 423 GLY A 425 5 3 HELIX 4 4 ASN A 451 ASN A 463 1 13 SHEET 1 A 4 VAL A 427 ILE A 434 0 SHEET 2 A 4 SER A 441 TYR A 449 -1 O SER A 448 N VAL A 428 SHEET 3 A 4 ASN A 402 TYR A 406 -1 N LEU A 403 O VAL A 447 SHEET 4 A 4 LYS A 473 LEU A 476 -1 O LYS A 473 N TYR A 406 SHEET 1 B 2 GLN A 466 ILE A 467 0 SHEET 2 B 2 LYS A 470 ARG A 471 -1 O LYS A 470 N ILE A 467 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1